As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Reviews, Research Highlights and Commentaries
Read the latest papers on pathogenic organisms and disease across BMC flagship journals.
Population-level mathematical modeling of antimicrobial resistance: a systematic review
Anna Maria Niewiadomska et al.
Published in BMC Medicine 24 April 2019
Published in BMC Biology 02 August 2018
INSaFLU: an automated open web-based bioinformatics suite “from-reads” for influenza whole-genome-sequencing-based surveillance
Vítor Borges et al.
Published in Genome Medicine 29 June 2018
HOPS: automated detection and authentication of pathogen DNA in archaeological remains
Ron Hübler et al.
Published in Genome Biology 16 December 2019
Aims and scope
Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.
A decade of Genome Medicine
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda
From genome integrity to cancer
Guest editor: Serena Nik-Zainal
Genomics of infection and immunity
Guest editors: Bali Pulendran and Mark Davis
From the blog
- Editorial Board
- Editorial Team
- Sign up for article alerts and news from this journal
- Contact us
In response to the current outbreak of Coronavirus, responsible for COVID-19, Genome Medicine editors will treat relevant submissions with high priority.